[在临界产科出血和严重创伤中传播的血管内凝血]
1Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|September 3, 2025
概括
在产科和创伤中传播的血管内凝血 (DIC) 涉及过敏纤维解和出血. 治疗重点是替代凝血因子,并使用抗纤维溶解剂治疗以改善存活率.
科学领域:
- 血液学
- 产科和妇科
- 创伤手术
背景情况:
- 传播性血管内凝血 (DIC) 是一种危及生命的疾病.
- 产科性DIC源于胎盘/胎儿组织因素,而创伤性DIC则涉及内皮损伤.
- 这两种情况都伴有消耗性凝血病和纤维素分解,使出血恶化.
研究的目的:
- 在临界产科出血和严重创伤中分类DIC.
- 阐明产科和创伤相关的DIC的独特病理触发因素.
- 突出这些DIC类型的共同特征和治疗策略.
主要方法:
- DIC的病理和进展分类.
- 对产科和创伤引起的DIC的病因因素的分析.
- 对高纤维解的DIC治疗策略的审查.
主要成果:
- 在产科和创伤中,DIC被分为纤维分析性和急性.
- 产科性DIC是由胎盘,羊水和乳液的组织因素引发的.
- 创伤性DIC,特别是创伤性脑损伤,涉及血管内皮损伤和组织因素.
结论:
- 有效的DIC治疗包括凝血因子替代和抗纤维解药疗法.
- 这些干预措施对于控制高纤维解和减少大量出血至关重要.
- 及时的治疗策略可以提高DIC患者的生存率.
相关概念视频
Introduction to Hemostasis
8.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.9K
Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K
Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Coagulation
7.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
889
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
889


